Genetics and genetic testing in pulmonary arterial hypertension
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2018, Vol 3, Issue 7
Abstract
Pulmonary arterial hypertension (PAH) is a rare disease with a high mortality and complex pathomechanism. Recent studies suggest an important role of genetic factors in the development of PAH. It was shown that patients with BMPR2 mutations present a disease at an earlier age and have more severe haemodynamics at diagnosis. Interestingly, in this disorder lifelong penetrance is estimated to be only about 20% and the mechanism of this phenomenon remains unknown. More recent studies focused on the mutational analysis of genes involved in TGFß signaling pathway in patients with PAH. The results of these studies are very promising but they still need to be confirmed. Moreover, data on the impact of identified mutations on the clinical course, PAH-specific treatment and prognosis in PAH is required. In Poland a multi-center study is planned to include patients from referral centers for pulmonary hypertension with diagnosed idiopathic, hereditary and drug-induced PAH or of pulmonary veno-occlusive disease (PVOD) and pulmonary capillary hemangiomatosis (PCH). The aim of the study is to perform an extended molecular analysis for better understanding the molecular basis of pathogenesis of PAH, incomplete penetrance and to create an algorithm of molecular diagnosis of PAH patients. On the basis of the nationwide registry of patients with PAH treated in referral centers in Poland the effect of the detected mutations on the clinical course, the effect of PAH-specific treatment and the prognosis in PAH will be assessed.
Authors and Affiliations
Ewa Lewicka, Alicja Dąbrowska‐Kugacka, Magdalena Chmara, Bartosz Wasąg
Keywords
Related Articles
- EP ID EP383467
- DOI 10.20418/jrcd.v3i7.322.g236
- Views 112
- Downloads 0
Right ventricular free wall motion abnormalities as a simple method of assessment in patients with pulmonary hypertension (RCD code: II‐1A.O)
Background: Pulmonary hypertension (PH) is a cardiovascular pathology leading to right-sided heart failure. A qualitative assessment of right ventricular (RV) function in echocardiography provides valuable information on...
A rare cause of the left ventricular outflow tract obstruction: accessory mitral valve tissue (RCD code: IV-1D.2o)
Accessory mitral valve tissue is a rare congenital malformation, which often causes left ventricular outflow tract (LVOT) obstruction. Patients with accessory MVT and LVOT obstruction have poor exercise tolerance, fatigu...
“One of the greatest disease is to be nobody to anybody”
Saint Mother Teresa of CalcuttaDear Readers,Before we go any further, try to ponder the quote once said by the Saint Teresa of Calcutta. She was by far one of the most entitled person in the world to say such an unpleasa...
Third Conference of the Pulmonary Circulation Task Force of the Polish Cardiac Society
Third Conference of the Pulmonary Circulation Task Force of the Polish Cardiac Society was held on 8th‑9th November 2013 in Golebiewski Hotel in Bialystok. The Scientific Committee of the Conference constituted Prof. Mar...
Journal of Rare Cardiovascular Diseases: After one year of life we are growing out from infancy
Dear Readers, Dear Friends and Colleagues, The fifth issue of the Journal of Rare Cardiovascular Diseases is now ready. At the end of the year 2013, being at the same time, the very first year of the Journal’s life, I wa...